Tai Wah CHAN

Person

Palo Alto, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Catheter for modification of agent formulation
- Patent number 7,819,855
- Issue date Oct 26, 2010
- Durect Corporation
- Tai Wah Chan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Catheter for modification of agent formulation
- Patent number 7,250,043
- Issue date Jul 31, 2007
- Durect Corporation
- Tai Wah Chan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Catheter for modification of agent formulation
- Patent number 6,629,969
- Issue date Oct 7, 2003
- Durect Corporation
- Tai Wah Chan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anhydrous crystalline 9-(1,3-dihydroxy-2-propoxymethyl)guanine
- Patent number 4,642,346
- Issue date Feb 10, 1987
- Syntex (U.S.A.) Inc.
- Tai W. Chan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline form of N-acetylmuramyl-L-.alpha.-aminobutyryl-D-isoglu...
- Patent number 4,629,782
- Issue date Dec 16, 1986
- Syntex (U.S.A.) Inc.
- Tai W. Chan
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CRYSTALLINE AND AMORPHOUS FORMS OF PALONOSETRON HYDROCHLORIDE
- Publication number 20160214976
- Publication date Jul 28, 2016
- Helsinn Healthcare SA
- Waldo MOSSI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMORPHOUS FORMS OF PALONOSETRON HYDROCHLORIDE
- Publication number 20150291581
- Publication date Oct 15, 2015
- Helsinn Healthcare SA
- Waldo MOSSI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMORPHOUS FORMS OF PALONOSETRON HYDROCHLORIDE
- Publication number 20140171646
- Publication date Jun 19, 2014
- Helsinn Healthcare SA
- Waldo MOSSI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
High Concentration Formulations of Opioids and Opioid Derivatives
- Publication number 20110136847
- Publication date Jun 9, 2011
- Tai Wah Chan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE AND AMORPHOUS FORMS OF PALONOSETRON HYDROCHLORIDE
- Publication number 20100105724
- Publication date Apr 29, 2010
- HELSINN HEALTHCARE SA
- Waldo Mossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Catheter for modification of agent formulation
- Publication number 20070185473
- Publication date Aug 9, 2007
- Durect Corporation
- Tai Wah Chan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Devices and methods for management of inflammation
- Publication number 20040115236
- Publication date Jun 17, 2004
- Tai Wah Chan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
High concentration formulations of opioids and opioid derivatives
- Publication number 20040102476
- Publication date May 27, 2004
- Tai Wah Chan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Catheter for modification of agent formulation
- Publication number 20040068251
- Publication date Apr 8, 2004
- Durect Corporation
- Tai Wah Chan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Catheter for modification of agent formulation
- Publication number 20030028174
- Publication date Feb 6, 2003
- Tai Wah Chan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Devices and methods for management of bone density
- Publication number 20020151876
- Publication date Oct 17, 2002
- Tai-Wah Chan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Tai Wah CHAN

Person

Patents Grantslast 30 patents

Catheter for modification of agent formulation

Catheter for modification of agent formulation

Catheter for modification of agent formulation

Anhydrous crystalline 9-(1,3-dihydroxy-2-propoxymethyl)guanine

Crystalline form of N-acetylmuramyl-L-.alpha.-aminobutyryl-D-isoglu...

Patents Applicationslast 30 patents

CRYSTALLINE AND AMORPHOUS FORMS OF PALONOSETRON HYDROCHLORIDE

AMORPHOUS FORMS OF PALONOSETRON HYDROCHLORIDE

AMORPHOUS FORMS OF PALONOSETRON HYDROCHLORIDE

High Concentration Formulations of Opioids and Opioid Derivatives

CRYSTALLINE AND AMORPHOUS FORMS OF PALONOSETRON HYDROCHLORIDE

Catheter for modification of agent formulation

Devices and methods for management of inflammation

High concentration formulations of opioids and opioid derivatives

Catheter for modification of agent formulation

Catheter for modification of agent formulation

Devices and methods for management of bone density